Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether radioactive iodine, as compared to
anti-thyroid medications, is a risk factor for the development or progression of
thyroid-associated ophthalmopathy in patients with hyperthyroidism due to Graves' disease.
The other aim of this study is to determine the incidence of the various ophthalmopathy
subtypes and the utility of orbital antibodies in the diagnosis, classification and
monitoring of patients with thyroid-associated ophthalmopathy.
Phase:
N/A
Details
Lead Sponsor:
Barwon Health
Collaborators:
National Health and Medical Research Council, Australia University of Melbourne